{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:27:41Z","timestamp":1779910061384,"version":"3.53.1"},"reference-count":113,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,14]]},"DOI":"10.7759\/cureus.73669","type":"journal-article","created":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:06:37Z","timestamp":1731582397000},"source":"Crossref","is-referenced-by-count":6,"title":["Pneumonia in Transplant Recipients: A Comprehensive Review of Diagnosis and Management"],"prefix":"10.7759","author":[{"given":"Ramakanth","family":"Pata","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kristeva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhanu","family":"Kosuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.3390\/jcm9041193","article-title":"Recent advances and clinical outcomes of kidney transplantation","volume":"9","author":"Thongprayoon C","year":"2020","unstructured":"Thongprayoon C, Hansrivijit P, Leeaphorn N, et al.. Recent advances and clinical outcomes of kidney transplantation. J Clin Med. 2020, 9:10.3390\/jcm9041193","journal-title":"J Clin Med"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1007\/s00408-020-00403-9","article-title":"Infectious complications in lung transplant recipients","volume":"198","author":"Trachuk P","year":"2020","unstructured":"Trachuk P, Bartash R, Abbasi M, Keene A. Infectious complications in lung transplant recipients. Lung. 2020, 198:879-87. 10.1007\/s00408-020-00403-9","journal-title":"Lung"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200309-1322SO","article-title":"Pulmonary complications of solid organ and hematopoietic stem cell transplantation","volume":"170","author":"Kotloff RM","year":"2004","unstructured":"Kotloff RM, Ahya VN, Crawford SW. Pulmonary complications of solid organ and hematopoietic stem cell transplantation. Am J Respir Crit Care Med. 2004, 170:22-48. 10.1164\/rccm.200309-1322SO","journal-title":"Am J Respir Crit Care Med"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01862-9","article-title":"Comparison of clinical outcomes between peripheral blood stem cells and peripheral blood stem cells plus bone marrow in myelodysplastic syndrome patients with haploidentical transplantation","volume":"58","author":"Chu M","year":"2023","unstructured":"Chu M, Hu S, Shen Y, et al.. Comparison of clinical outcomes between peripheral blood stem cells and peripheral blood stem cells plus bone marrow in myelodysplastic syndrome patients with haploidentical transplantation. Bone Marrow Transplant. 2023, 58:142-51. 10.1038\/s41409-022-01862-9","journal-title":"Bone Marrow Transplant"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.7150\/jca.46081","article-title":"Reduced-intensity versus myeloablative conditioning regimens for younger adults with acute myeloid leukemia and myelodysplastic syndrome: a systematic review and meta-analysis","volume":"11","author":"Ma S","year":"2020","unstructured":"Ma S, Shi W, Li Z, Tang L, Wang H, Xia L, Hu Y. Reduced-intensity versus myeloablative conditioning regimens for younger adults with acute myeloid leukemia and myelodysplastic syndrome: a systematic review and meta-analysis. J Cancer. 2020, 11:5223-35. 10.7150\/jca.46081","journal-title":"J Cancer"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0284476","article-title":"Systematic review and meta-analysis of anti-thymocyte globulin dosage as a component of graft-versus-host disease prophylaxis","volume":"18","author":"Zuckermann J","year":"2023","unstructured":"Zuckermann J, Castro BM, Cunha TA, Paz A, Moreira LB. Systematic review and meta-analysis of anti-thymocyte globulin dosage as a component of graft-versus-host disease prophylaxis. PLoS One. 2023, 18:e0284476. 10.1371\/journal.pone.0284476","journal-title":"PLoS One"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2020-142799","article-title":"Functional B cell reconstitution following allogeneic stem cell transplantation","volume":"136","author":"Ho TN","year":"2020","unstructured":"Ho TN, Khan M, Clark B, Krieger E, Roberts CH, Toor AA. Functional B cell reconstitution following allogeneic stem cell transplantation. Blood. 2020, 136:40. 10.1182\/blood-2020-142799","journal-title":"Blood"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/978-0-387-78580-6_1","article-title":"Principles and overview of allogeneic hematopoietic stem cell transplantation","volume":"144","author":"Giralt S","year":"2009","unstructured":"Giralt S, Bishop MR. Principles and overview of allogeneic hematopoietic stem cell transplantation. Cancer Treat Res. 2009, 144:1-21. 10.1007\/978-0-387-78580-6_1","journal-title":"Cancer Treat Res"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1002\/phar.2481","article-title":"Immunosuppression trends in solid organ transplantation: the future of individualization, monitoring, and management","volume":"41","author":"Pilch NA","year":"2021","unstructured":"Pilch NA, Bowman LJ, Taber DJ. Immunosuppression trends in solid organ transplantation: the future of individualization, monitoring, and management. Pharmacotherapy. 2021, 41:119-31. 10.1002\/phar.2481","journal-title":"Pharmacotherapy"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.2165\/00002512-200522120-00002","article-title":"Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies","volume":"22","author":"Robak T","year":"2005","unstructured":"Robak T. Therapy of chronic lymphocytic leukaemia with purine nucleoside analogues: facts and controversies. Drugs Aging. 2005, 22:983-1012. 10.2165\/00002512-200522120-00002","journal-title":"Drugs Aging"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00575","article-title":"HLA mismatching strategies for solid organ transplantation - a balancing act","volume":"7","author":"Zachary AA","year":"2016","unstructured":"Zachary AA, Leffell MS. HLA mismatching strategies for solid organ transplantation - a balancing act. Front Immunol. 2016, 7:575. 10.3389\/fimmu.2016.00575","journal-title":"Front Immunol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.3390\/v16030459","article-title":"Torque teno virus DNA load in blood as an immune status biomarker in adult hematological patients: the state of the art and future prospects","volume":"16","author":"Albert E","year":"2024","unstructured":"Albert E, Gim\u00e9nez E, Hernani R, Pi\u00f1ana JL, Solano C, Navarro D. Torque teno virus DNA load in blood as an immune status biomarker in adult hematological patients: the state of the art and future prospects. Viruses. 2024, 16:10.3390\/v16030459","journal-title":"Viruses"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2019.01694","article-title":"Techniques to study antigen-specific B cell responses","volume":"10","author":"Boonyaratanakornkit J","year":"2019","unstructured":"Boonyaratanakornkit J, Taylor JJ. Techniques to study antigen-specific B cell responses. Front Immunol. 2019, 10:1694. 10.3389\/fimmu.2019.01694","journal-title":"Front Immunol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.25418","article-title":"An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer","volume":"94","author":"Feins S","year":"2019","unstructured":"Feins S, Kong W, Williams EF, Milone MC, Fraietta JA. An introduction to chimeric antigen receptor (CAR) T-cell immunotherapy for human cancer. Am J Hematol. 2019, 94:S3-9. 10.1002\/ajh.25418","journal-title":"Am J Hematol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1177\/20499361211036773","article-title":"Infectious complications of CAR T-cell therapy: a clinical update","volume":"8","author":"Stewart AG","year":"2021","unstructured":"Stewart AG, Henden AS. Infectious complications of CAR T-cell therapy: a clinical update. Ther Adv Infect Dis. 2021, 8:20499361211036773. 10.1177\/20499361211036773","journal-title":"Ther Adv Infect Dis"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004000","article-title":"How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies","volume":"136","author":"Hill JA","year":"2020","unstructured":"Hill JA, Seo SK. How I prevent infections in patients receiving CD19-targeted chimeric antigen receptor T cells for B-cell malignancies. Blood. 2020, 136:925-35. 10.1182\/blood.2019004000","journal-title":"Blood"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciw295","article-title":"Inpatient mortality among solid organ transplant recipients hospitalized for sepsis and severe sepsis","volume":"63","author":"Donnelly JP","year":"2016","unstructured":"Donnelly JP, Locke JE, MacLennan PA, et al.. Inpatient mortality among solid organ transplant recipients hospitalized for sepsis and severe sepsis. Clin Infect Dis. 2016, 63:186-94. 10.1093\/cid\/ciw295","journal-title":"Clin Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1378\/chest.12-1708","article-title":"An update on pulmonary complications of hematopoietic stem cell transplantation","volume":"144","author":"Chi AK","year":"2013","unstructured":"Chi AK, Soubani AO, White AC, Miller KB. An update on pulmonary complications of hematopoietic stem cell transplantation. Chest. 2013, 144:1913-22. 10.1378\/chest.12-1708","journal-title":"Chest"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1128\/microbiolspec.DMIH2-0026-2016","article-title":"Overview of infections in the immunocompromised host","volume":"4","author":"Dropulic LK","year":"2016","unstructured":"Dropulic LK, Lederman HM. Overview of infections in the immunocompromised host. Microbiol Spectr. 2016, 4:10.1128\/microbiolspec.DMIH2-0026-2016","journal-title":"Microbiol Spectr"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000502","article-title":"Invasive fungal disease and cytomegalovirus infection: is there an association?","volume":"31","author":"Yong MK","year":"2018","unstructured":"Yong MK, Slavin MA, Kontoyiannis DP. Invasive fungal disease and cytomegalovirus infection: is there an association?. Curr Opin Infect Dis. 2018, 31:481-9. 10.1097\/QCO.0000000000000502","journal-title":"Curr Opin Infect Dis"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.3389\/fcimb.2020.00130","article-title":"Cytomegalovirus latency and reactivation: an intricate interplay with the host immune response","volume":"10","author":"Forte E","year":"2020","unstructured":"Forte E, Zhang Z, Thorp EB, Hummel M. Cytomegalovirus latency and reactivation: an intricate interplay with the host immune response. Front Cell Infect Microbiol. 2020, 10:130. 10.3389\/fcimb.2020.00130","journal-title":"Front Cell Infect Microbiol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-9034-4_40","article-title":"Respiratory viral infections in transplant recipients","author":"Liu C","year":"2018","unstructured":"Liu C, Ho DY, Boeckh M. Respiratory viral infections in transplant recipients. Principles and Practice of Transplant Infectious Diseases. Safdar A (ed): Springer, New York, NY; 2018. 679-95. 10.1007\/978-1-4939-9034-4_40"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1016\/B978-0-323-44942-7.00095-9","article-title":"Management of infection in patients with kidney transplant","author":"Cawcutt KA","year":"2018","unstructured":"Cawcutt KA, Zimmer A. Management of infection in patients with kidney transplant. Critical Care Nephrology. 2018, 552-560.e1. 10.1016\/B978-0-323-44942-7.00095-9","journal-title":"Critical Care Nephrology"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/ajt.14208","article-title":"Infection in organ transplantation","volume":"17","author":"Fishman JA","year":"2017","unstructured":"Fishman JA. Infection in organ transplantation. Am J Transplant. 2017, 17:856-79. 10.1111\/ajt.14208","journal-title":"Am J Transplant"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciu522","article-title":"Impact of infectious disease consultation on the clinical and economic outcomes of solid organ transplant recipients admitted for infectious complications","volume":"59","author":"Hamandi B","year":"2014","unstructured":"Hamandi B, Husain S, Humar A, Papadimitropoulos EA. Impact of infectious disease consultation on the clinical and economic outcomes of solid organ transplant recipients admitted for infectious complications. Clin Infect Dis. 2014, 59:1074-82. 10.1093\/cid\/ciu522","journal-title":"Clin Infect Dis"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1111\/j.1600-6143.2008.02304.x","article-title":"Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients","volume":"8","author":"Russell DL","year":"2008","unstructured":"Russell DL, Flood A, Zaroda TE, Acosta C, Riley MM, Busuttil RW, Pegues DA. Outcomes of colonization with MRSA and VRE among liver transplant candidates and recipients. Am J Transplant. 2008, 8:1737-43. 10.1111\/j.1600-6143.2008.02304.x","journal-title":"Am J Transplant"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1111\/trf.14994","article-title":"The burden of invasive infections in neutropenic patients: incidence, outcomes, and use of granulocyte transfusions","volume":"59","author":"Netelenbos T","year":"2019","unstructured":"Netelenbos T, Massey E, de Wreede LC, et al.. The burden of invasive infections in neutropenic patients: incidence, outcomes, and use of granulocyte transfusions. Transfusion. 2019, 59:160-8. 10.1111\/trf.14994","journal-title":"Transfusion"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22020523","article-title":"Role of CD4+ T cells in the control of viral infections: recent advances and open questions","volume":"22","author":"Kervevan J","year":"2021","unstructured":"Kervevan J, Chakrabarti LA. Role of CD4+ T cells in the control of viral infections: recent advances and open questions. Int J Mol Sci. 2021, 22:10.3390\/ijms22020523","journal-title":"Int J Mol Sci"},{"key":"ref29","doi-asserted-by":"publisher","DOI":"10.1007\/s12281-023-00456-2","article-title":"The impact of corticosteroids on the outcome of fungal disease: a systematic review and meta-analysis","volume":"17","author":"Li Z","year":"2023","unstructured":"Li Z, Denning DW. The impact of corticosteroids on the outcome of fungal disease: a systematic review and meta-analysis. Curr Fungal Infect Rep. 2023, 17:54-70. 10.1007\/s12281-023-00456-2","journal-title":"Curr Fungal Infect Rep"},{"key":"ref30","doi-asserted-by":"publisher","DOI":"10.3389\/fmed.2022.942665","article-title":"Belatacept in kidney transplantation: what are the true benefits? A systematic review","volume":"9","author":"Lombardi Y","year":"2022","unstructured":"Lombardi Y, Fran\u00e7ois H. Belatacept in kidney transplantation: what are the true benefits? A systematic review. Front Med (Lausanne). 2022, 9:942665. 10.3389\/fmed.2022.942665","journal-title":"Front Med (Lausanne)"},{"key":"ref31","doi-asserted-by":"publisher","DOI":"10.5500\/wjt.v9.i6.103","article-title":"Therapeutic apheresis in kidney transplantation: an updated review","volume":"9","author":"Salvadori M","year":"2019","unstructured":"Salvadori M, Tsalouchos A. Therapeutic apheresis in kidney transplantation: an updated review. World J Transplant. 2019, 9:103-22. 10.5500\/wjt.v9.i6.103","journal-title":"World J Transplant"},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/jca.21470","article-title":"Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the american society for apheresis: the seventh special issue","volume":"31","author":"Schwartz J","year":"2016","unstructured":"Schwartz J, Padmanabhan A, Aqui N, et al.. Guidelines on the use of therapeutic apheresis in clinical practice-evidence-based approach from the writing committee of the american society for apheresis: the seventh special issue. J Clin Apher. 2016, 31:149-62. 10.1002\/jca.21470","journal-title":"J Clin Apher"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.3904\/kjim.2018.036","article-title":"Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea","volume":"33","author":"Cho SY","year":"2018","unstructured":"Cho SY, Lee HJ, Lee DG. Infectious complications after hematopoietic stem cell transplantation: current status and future perspectives in Korea. Korean J Intern Med. 2018, 33:256-76. 10.3904\/kjim.2018.036","journal-title":"Korean J Intern Med"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2010.11.008","article-title":"Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology","volume":"25","author":"Wingard JR","year":"2011","unstructured":"Wingard JR, Hsu J, Hiemenz JW. Hematopoietic stem cell transplantation: an overview of infection risks and epidemiology. Hematol Oncol Clin North Am. 2011, 25:101-16. 10.1016\/j.hoc.2010.11.008","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1007\/s15010-020-01407-6","article-title":"Pre-engraftment infectious complications and patient outcomes after allogeneic hematopoietic cell transplantation: a single-center experience from Lebanon","volume":"48","author":"Moghnieh R","year":"2020","unstructured":"Moghnieh R, Tamim H, Abyad A, et al.. Pre-engraftment infectious complications and patient outcomes after allogeneic hematopoietic cell transplantation: a single-center experience from Lebanon. Infection. 2020, 48:385-401. 10.1007\/s15010-020-01407-6","journal-title":"Infection"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199305063281808","article-title":"Management of fever in patients with cancer and treatment-induced neutropenia","volume":"328","author":"Pizzo PA","year":"1993","unstructured":"Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med. 1993, 328:1323-32. 10.1056\/NEJM199305063281808","journal-title":"N Engl J Med"},{"key":"ref37","article-title":"Pulmonary invasive fungal disease and bacterial pneumonia: a comparative study with high-resolution CT","volume":"11","author":"Chen W","year":"2019","unstructured":"Chen W, Xiong X, Xie B, et al.. Pulmonary invasive fungal disease and bacterial pneumonia: a comparative study with high-resolution CT. Am J Transl Res. 2019, 11:4542-51.","journal-title":"Am J Transl Res"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s12032-022-01894-7","article-title":"Engraftment syndrome following Hematopoietic stem cell transplantation: a systematic approach toward diagnosis and management","volume":"40","author":"Maqbool S","year":"2022","unstructured":"Maqbool S, Nadeem M, Shahroz A, et al.. Engraftment syndrome following Hematopoietic stem cell transplantation: a systematic approach toward diagnosis and management. Med Oncol. 2022, 40:36. 10.1007\/s12032-022-01894-7","journal-title":"Med Oncol"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2006-07-034348","article-title":"Hyperacute GVHD: risk factors, outcomes, and clinical implications","volume":"109","author":"Saliba RM","year":"2007","unstructured":"Saliba RM, de Lima M, Giralt S, et al.. Hyperacute GVHD: risk factors, outcomes, and clinical implications. Blood. 2007, 109:2751-8. 10.1182\/blood-2006-07-034348","journal-title":"Blood"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-030-26710-0_33","article-title":"Diffuse alveolar hemorrhage","author":"Desai H","year":"2019","unstructured":"Desai H, Smith J, Williams MD. Diffuse alveolar hemorrhage. Evidence-Based Critical Care. 2019, 253-7. 10.1007\/978-3-030-26710-0_33","journal-title":"Evidence-Based Critical Care"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-63146-2_21","article-title":"Pulmonary complications associated with HSCT","author":"Kapadia M","year":"2017","unstructured":"Kapadia M, Shapiro TW. Pulmonary complications associated with HSCT. Hematopoietic Stem Cell Transplantation for the Pediatric Hematologist\/Oncologist. Brown V (ed): Springer, Cham; 2017. 301-25. 10.1007\/978-3-319-63146-2_21"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.5772\/intechopen.89868","article-title":"Invasive aspergillosis in transplant recipients","author":"Wr\u00f3blewska M","year":"2019","unstructured":"Wr\u00f3blewska M, Sulik-Tyszka B, Figiel W, Niewi\u0144ski G, Zieniewicz K. Invasive aspergillosis in transplant recipients. Surgical Recovery. Sozen S (ed): IntechOpen, 2019. 10.5772\/intechopen.89868"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.09.034","article-title":"Incidence, risk factors, and outcomes of idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation","volume":"26","author":"Wenger DS","year":"2020","unstructured":"Wenger DS, Triplette M, Crothers K, et al.. Incidence, risk factors, and outcomes of idiopathic pneumonia syndrome after allogeneic hematopoietic cell transplantation. Biol Blood Marrow Transplant. 2020, 26:413-20. 10.1016\/j.bbmt.2019.09.034","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.11.012","article-title":"Noninfectious pulmonary complications after hematopoietic stem cell transplantation","volume":"29","author":"Fraebel J","year":"2023","unstructured":"Fraebel J, Engelhardt BG, Kim TK. Noninfectious pulmonary complications after hematopoietic stem cell transplantation. Transplant Cell Ther. 2023, 29:82-93. 10.1016\/j.jtct.2022.11.012","journal-title":"Transplant Cell Ther"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkw155","article-title":"Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients","volume":"71","author":"Cordonnier C","year":"2016","unstructured":"Cordonnier C, Cesaro S, Maschmeyer G, et al.. Pneumocystis jirovecii pneumonia: still a concern in patients with haematological malignancies and stem cell transplant recipients. J Antimicrob Chemother. 2016, 71:2379-85. 10.1093\/jac\/dkw155","journal-title":"J Antimicrob Chemother"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1186\/s12964-023-01122-3","article-title":"Spotlight on the impact of viral infections on hematopoietic stem cells (HSCs) with a focus on COVID-19 effects","volume":"21","author":"Nasiri K","year":"2023","unstructured":"Nasiri K, Mohammadzadehsaliani S, Kheradjoo H, et al.. Spotlight on the impact of viral infections on hematopoietic stem cells (HSCs) with a focus on COVID-19 effects. Cell Commun Signal. 2023, 21:103. 10.1186\/s12964-023-01122-3","journal-title":"Cell Commun Signal"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.1007\/s40506-021-00253-w","article-title":"CMV infection in hematopoietic stem cell transplantation: prevention and treatment strategies","volume":"13","author":"Jakharia N","year":"2021","unstructured":"Jakharia N, Howard D, Riedel DJ. CMV infection in hematopoietic stem cell transplantation: prevention and treatment strategies. Curr Treat Options Infect Dis. 2021, 13:123-40. 10.1007\/s40506-021-00253-w","journal-title":"Curr Treat Options Infect Dis"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0b013e3283551dbd","article-title":"Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis","volume":"25","author":"Mejia R","year":"2012","unstructured":"Mejia R, Nutman TB. Screening, prevention, and treatment for hyperinfection syndrome and disseminated infections caused by Strongyloides stercoralis. Curr Opin Infect Dis. 2012, 25:458-63. 10.1097\/QCO.0b013e3283551dbd","journal-title":"Curr Opin Infect Dis"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1111\/tid.13636","article-title":"Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers","volume":"23","author":"Adekunle RO","year":"2021","unstructured":"Adekunle RO, Sherman A, Spicer JO, et al.. Clinical characteristics and outcomes of toxoplasmosis among transplant recipients at two US academic medical centers. Transpl Infect Dis. 2021, 23:e13636. 10.1111\/tid.13636","journal-title":"Transpl Infect Dis"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jtct.2022.12.004","article-title":"Risk factors and outcomes of nocardiosis in hematopoietic stem cell transplantation recipients","volume":"29","author":"Yetmar ZA","year":"2023","unstructured":"Yetmar ZA, Thoendel MJ, Bosch W, Seville MT, Hogan WJ, Beam E. Risk factors and outcomes of nocardiosis in hematopoietic stem cell transplantation recipients. Transplant Cell Ther. 2023, 29:206.e1-7. 10.1016\/j.jtct.2022.12.004","journal-title":"Transplant Cell Ther"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2019.03.009","article-title":"Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-a consensus report from the Pulmonary Council of the ISHLT","volume":"38","author":"Verleden GM","year":"2019","unstructured":"Verleden GM, Glanville AR, Lease ED, et al.. Chronic lung allograft dysfunction: definition, diagnostic criteria, and approaches to treatment-a consensus report from the Pulmonary Council of the ISHLT. J Heart Lung Transplant. 2019, 38:493-503. 10.1016\/j.healun.2019.03.009","journal-title":"J Heart Lung Transplant"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciz1113","article-title":"Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss Transplant Cohort Study","volume":"71","author":"van Delden C","year":"2020","unstructured":"van Delden C, Stampf S, Hirsch HH, et al.. Burden and timeline of infectious diseases in the first year after solid organ transplantation in the Swiss Transplant Cohort Study. Clin Infect Dis. 2020, 71:e159-69. 10.1093\/cid\/ciz1113","journal-title":"Clin Infect Dis"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac337","article-title":"Notifiable infectious diseases among organ transplant recipients: a data-linked cohort study, 2000-2015","volume":"9","author":"Waller KM","year":"2022","unstructured":"Waller KM, De La Mata NL, Wyburn KR, et al.. Notifiable infectious diseases among organ transplant recipients: a data-linked cohort study, 2000-2015. Open Forum Infect Dis. 2022, 9:ofac337. 10.1093\/ofid\/ofac337","journal-title":"Open Forum Infect Dis"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1186\/s41479-022-00096-z","article-title":"Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns","volume":"14","author":"Assefa M","year":"2022","unstructured":"Assefa M. Multi-drug resistant gram-negative bacterial pneumonia: etiology, risk factors, and drug resistance patterns. Pneumonia (Nathan). 2022, 14:4. 10.1186\/s41479-022-00096-z","journal-title":"Pneumonia (Nathan)"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13588","article-title":"Management of infections due to nontuberculous mycobacteria in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Longworth SA","year":"2019","unstructured":"Longworth SA, Daly JS. Management of infections due to nontuberculous mycobacteria in solid organ transplant recipients-Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019, 33:e13588. 10.1111\/ctr.13588","journal-title":"Clin Transplant"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.3947\/ic.2013.45.3.260","article-title":"Cytomegalovirus infections in solid organ transplantation: a review","volume":"45","author":"Ramanan P","year":"2013","unstructured":"Ramanan P, Razonable RR. Cytomegalovirus infections in solid organ transplantation: a review. Infect Chemother. 2013, 45:260-71. 10.3947\/ic.2013.45.3.260","journal-title":"Infect Chemother"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-022-01756-w","article-title":"Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy","volume":"57","author":"Wudhikarn K","year":"2022","unstructured":"Wudhikarn K, Perales MA. Infectious complications, immune reconstitution, and infection prophylaxis after CD19 chimeric antigen receptor T-cell therapy. Bone Marrow Transplant. 2022, 57:1477-88. 10.1038\/s41409-022-01756-w","journal-title":"Bone Marrow Transplant"},{"key":"ref58","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.947648","article-title":"Cytokines as an important player in the context of CAR-T cell therapy for cancer: their role in tumor immunomodulation, manufacture, and clinical implications","volume":"13","author":"Silveira CR","year":"2022","unstructured":"Silveira CR, Corveloni AC, Caruso SR, et al.. Cytokines as an important player in the context of CAR-T cell therapy for cancer: their role in tumor immunomodulation, manufacture, and clinical implications. Front Immunol. 2022, 13:947648. 10.3389\/fimmu.2022.947648","journal-title":"Front Immunol"},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.1186\/1710-1492-6-9","article-title":"Clinical experience in T cell deficient patients","volume":"6","author":"Cole TS","year":"2010","unstructured":"Cole TS, Cant AJ. Clinical experience in T cell deficient patients. Allergy Asthma Clin Immunol. 2010, 6:9. 10.1186\/1710-1492-6-9","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-19617-6_22","article-title":"Infection in kidney transplantation","author":"Nambiar P","year":"2018","unstructured":"Nambiar P, Silibovsky R, Belden KA. Infection in kidney transplantation. Contemporary Kidney Transplantation. Ramirez C, McCauley J (ed): Springer, Cham; 2018. 307-27. 10.1007\/978-3-319-19617-6_22"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13545","article-title":"Pneumonia in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Dulek DE","year":"2019","unstructured":"Dulek DE, Mueller NJ. Pneumonia in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019, 33:e13545. 10.1111\/ctr.13545","journal-title":"Clin Transplant"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00042-19","article-title":"Community-acquired respiratory viruses in transplant patients: diversity, impact, unmet clinical needs","volume":"32","author":"Ison MG","year":"2019","unstructured":"Ison MG, Hirsch HH. Community-acquired respiratory viruses in transplant patients: diversity, impact, unmet clinical needs. Clin Microbiol Rev. 2019, 32:10.1128\/CMR.00042-19","journal-title":"Clin Microbiol Rev"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.1111\/irv.12170","article-title":"Influenza prevention and treatment in transplant recipients and immunocompromised hosts","volume":"7 Suppl 3","author":"Ison MG","year":"2013","unstructured":"Ison MG. Influenza prevention and treatment in transplant recipients and immunocompromised hosts. Influenza Other Respir Viruses. 2013, 7 Suppl 3:60-6. 10.1111\/irv.12170","journal-title":"Influenza Other Respir Viruses"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2018.12.005","article-title":"Human rhinovirus infections in hematopoietic cell transplant recipients: risk score for progression to lower respiratory tract infection","volume":"25","author":"Waghmare A","year":"2019","unstructured":"Waghmare A, Xie H, Kuypers J, et al.. Human rhinovirus infections in hematopoietic cell transplant recipients: risk score for progression to lower respiratory tract infection. Biol Blood Marrow Transplant. 2019, 25:1011-21. 10.1016\/j.bbmt.2018.12.005","journal-title":"Biol Blood Marrow Transplant"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.200604-489OC","article-title":"Chronic rhinoviral infection in lung transplant recipients","volume":"174","author":"Kaiser L","year":"2006","unstructured":"Kaiser L, Aubert JD, Pache JC, et al.. Chronic rhinoviral infection in lung transplant recipients. Am J Respir Crit Care Med. 2006, 174:1392-9. 10.1164\/rccm.200604-489OC","journal-title":"Am J Respir Crit Care Med"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.1016\/j.imlet.2020.06.013","article-title":"Lymphopenia during the COVID-19 infection: what it shows and what can be learned","volume":"225","author":"Tavakolpour S","year":"2020","unstructured":"Tavakolpour S, Rakhshandehroo T, Wei EX, Rashidian M. Lymphopenia during the COVID-19 infection: what it shows and what can be learned. Immunol Lett. 2020, 225:31-2. 10.1016\/j.imlet.2020.06.013","journal-title":"Immunol Lett"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13526","article-title":"Herpes simplex virus infections in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Lee DH","year":"2019","unstructured":"Lee DH, Zuckerman RA. Herpes simplex virus infections in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019, 33:e13526. 10.1111\/ctr.13526","journal-title":"Clin Transplant"},{"key":"ref68","article-title":"Prophylactic pretransplant ganciclovir to reduce cytomegalovirus infection after hematopoietic stem cell transplantation","volume":"16","author":"Reed DR","year":"2023","unstructured":"Reed DR, Petroni GR, West M, et al.. Prophylactic pretransplant ganciclovir to reduce cytomegalovirus infection after hematopoietic stem cell transplantation. Hematol Oncol Stem Cell Ther. 2023, 16:61-9.","journal-title":"Hematol Oncol Stem Cell Ther"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1007\/s40121-017-0180-z","article-title":"Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation","volume":"7","author":"Styczynski J","year":"2018","unstructured":"Styczynski J. Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation. Infect Dis Ther. 2018, 7:1-16. 10.1007\/s40121-017-0180-z","journal-title":"Infect Dis Ther"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1007\/s11908-019-0699-0","article-title":"CMV prevention and treatment in transplantation: what's new in 2019","volume":"21","author":"Stern A","year":"2019","unstructured":"Stern A, Papanicolaou GA. CMV prevention and treatment in transplantation: what's new in 2019. Curr Infect Dis Rep. 2019, 21:45. 10.1007\/s11908-019-0699-0","journal-title":"Curr Infect Dis Rep"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.1016\/j.trre.2016.12.001","article-title":"Epstein-Barr virus and renal transplantation","volume":"31","author":"Le J","year":"2017","unstructured":"Le J, Durand CM, Agha I, Brennan DC. Epstein-Barr virus and renal transplantation. Transplant Rev (Orlando). 2017, 31:55-60. 10.1016\/j.trre.2016.12.001","journal-title":"Transplant Rev (Orlando)"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13652","article-title":"Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Allen UD","year":"2019","unstructured":"Allen UD, Preiksaitis JK. Post-transplant lymphoproliferative disorders, Epstein-Barr virus infection, and disease in solid organ transplantation: Guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019, 33:e13652. 10.1111\/ctr.13652","journal-title":"Clin Transplant"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1097\/QCO.0000000000000592","article-title":"Human herpesvirus 6 in transplant recipients: an update on diagnostic and treatment strategies","volume":"32","author":"Hill JA","year":"2019","unstructured":"Hill JA. Human herpesvirus 6 in transplant recipients: an update on diagnostic and treatment strategies. Curr Opin Infect Dis. 2019, 32:584-90. 10.1097\/QCO.0000000000000592","journal-title":"Curr Opin Infect Dis"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(01)06808-8","article-title":"Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis","volume":"358","author":"Soyza AD","year":"2001","unstructured":"Soyza AD, McDowell A, Archer L, et al.. Burkholderia cepacia complex genomovars and pulmonary transplantation outcomes in patients with cystic fibrosis. Lancet. 2001, 358:1780-81. 10.1016\/S0140-6736(01)06808-8","journal-title":"Lancet"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-018-0391-2","article-title":"Pneumocystis jirovecii pneumonia prophylaxis in allogeneic hematopoietic cell transplant recipients: can we always follow the guidelines?","volume":"54","author":"Redjoul R","year":"2019","unstructured":"Redjoul R, Robin C, Foulet F, et al.. Pneumocystis jirovecii pneumonia prophylaxis in allogeneic hematopoietic cell transplant recipients: can we always follow the guidelines?. Bone Marrow Transplant. 2019, 54:1082-8. 10.1038\/s41409-018-0391-2","journal-title":"Bone Marrow Transplant"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2015.316","article-title":"The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis","volume":"51","author":"Williams KM","year":"2016","unstructured":"Williams KM, Ahn KW, Chen M, et al.. The incidence, mortality and timing of Pneumocystis jiroveci pneumonia after hematopoietic cell transplantation: a CIBMTR analysis. Bone Marrow Transplant. 2016, 51:573-80. 10.1038\/bmt.2015.316","journal-title":"Bone Marrow Transplant"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13587","article-title":"Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice","volume":"33","author":"Fishman JA","year":"2019","unstructured":"Fishman JA, Gans H. Pneumocystis jiroveci in solid organ transplantation: guidelines from the American Society of Transplantation Infectious Diseases Community of Practice. Clin Transplant. 2019, 33:e13587. 10.1111\/ctr.13587","journal-title":"Clin Transplant"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1177\/20499361211039050","article-title":"Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management","volume":"8","author":"Rahi MS","year":"2021","unstructured":"Rahi MS, Jindal V, Pednekar P, et al.. Fungal infections in hematopoietic stem-cell transplant patients: a review of epidemiology, diagnosis, and management. Ther Adv Infect Dis. 2021, 8:20499361211039050. 10.1177\/20499361211039050","journal-title":"Ther Adv Infect Dis"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.3390\/jof9020131","article-title":"Invasive pulmonary aspergillosis","volume":"9","author":"Ledoux MP","year":"2023","unstructured":"Ledoux MP, Herbrecht R. Invasive pulmonary aspergillosis. J Fungi (Basel). 2023, 9:10.3390\/jof9020131","journal-title":"J Fungi (Basel)"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1007\/978-90-481-2408-4_34","article-title":"Invasive pulmonary aspergillosis in solid organ transplant recipients","author":"Silveira FP","year":"2010","unstructured":"Silveira FP, Husain S. Invasive pulmonary aspergillosis in solid organ transplant recipients. Aspergillosis: From Diagnosis to Prevention. Pasqualotto C (ed): Springer, Dordrecht; 2010. 567-81. 10.1007\/978-90-481-2408-4_34"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra2027424","article-title":"Aspergillus infections","volume":"385","author":"Thompson GR 3rd","year":"2021","unstructured":"Thompson GR 3rd, Young JH. Aspergillus infections. N Engl J Med. 2021, 385:1496-509. 10.1056\/NEJMra2027424","journal-title":"N Engl J Med"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofaa646","article-title":"Mucormycosis in hematopoietic cell transplant recipients and in patients with hematological malignancies in the era of new antifungal agents","volume":"8","author":"Miller MA","year":"2021","unstructured":"Miller MA, Molina KC, Gutman JA, et al.. Mucormycosis in hematopoietic cell transplant recipients and in patients with hematological malignancies in the era of new antifungal agents. Open Forum Infect Dis. 2021, 8:ofaa646. 10.1093\/ofid\/ofaa646","journal-title":"Open Forum Infect Dis"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1186\/s13613-021-00923-4","article-title":"Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements","volume":"11","author":"Montrucchio G","year":"2021","unstructured":"Montrucchio G, Lupia T, Lombardo D, Stroffolini G, Corcione S, De Rosa FG, Brazzi L. Risk factors for invasive aspergillosis in ICU patients with COVID-19: current insights and new key elements. Ann Intensive Care. 2021, 11:136. 10.1186\/s13613-021-00923-4","journal-title":"Ann Intensive Care"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1378\/chest.119.1.169","article-title":"Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature","volume":"119","author":"Mehrad B","year":"2001","unstructured":"Mehrad B, Paciocco G, Martinez FJ, Ojo TC, Iannettoni MD, Lynch JP 3rd. Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature. Chest. 2001, 119:169-75. 10.1378\/chest.119.1.169","journal-title":"Chest"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0b013e318207612d","article-title":"Fusarium infection in lung transplant patients: report of 6 cases and review of the literature","volume":"90","author":"Carneiro HA","year":"2011","unstructured":"Carneiro HA, Coleman JJ, Restrepo A, Mylonakis E. Fusarium infection in lung transplant patients: report of 6 cases and review of the literature. Medicine (Baltimore). 2011, 90:69-80. 10.1097\/MD.0b013e318207612d","journal-title":"Medicine (Baltimore)"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1055\/s-0043-1777259","article-title":"Aspergillus and the Lung","volume":"45","author":"Janssens I","year":"2024","unstructured":"Janssens I, Lambrecht BN, Van Braeckel E. Aspergillus and the Lung. Semin Respir Crit Care Med. 2024, 45:3-20. 10.1055\/s-0043-1777259","journal-title":"Semin Respir Crit Care Med"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.3390\/jof5030079","article-title":"Central nervous system infections due to Aspergillus and other hyaline molds","volume":"5","author":"Miceli MH","year":"2019","unstructured":"Miceli MH. Central nervous system infections due to Aspergillus and other hyaline molds. J Fungi (Basel). 2019, 5:10.3390\/jof5030079","journal-title":"J Fungi (Basel)"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1007\/s10875-023-01615-3","article-title":"Prevalence and characteristics of non-tuberculous mycobacteria (NTM) infection in recipients of allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis","volume":"44","author":"Cinicola BL","year":"2023","unstructured":"Cinicola BL, Ottaviano G, Hashim IF, Zainudeen ZT, Hamid IJ, Elfeky R. Prevalence and characteristics of non-tuberculous mycobacteria (NTM) infection in recipients of allogeneic hematopoietic stem cell transplantation: a systematic review and meta-analysis. J Clin Immunol. 2023, 44:23. 10.1007\/s10875-023-01615-3","journal-title":"J Clin Immunol"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.1111\/ctr.13259","article-title":"Mycobacterium tuberculosis after solid organ transplantation: a review of more than 2000 cases","volume":"32","author":"Abad CL","year":"2018","unstructured":"Abad CL, Razonable RR. Mycobacterium tuberculosis after solid organ transplantation: a review of more than 2000 cases. Clin Transplant. 2018, 32:e13259. 10.1111\/ctr.13259","journal-title":"Clin Transplant"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra064928","article-title":"Infection in solid-organ transplant recipients","volume":"357","author":"Fishman JA","year":"2007","unstructured":"Fishman JA. Infection in solid-organ transplant recipients. N Engl J Med. 2007, 357:2601-14. 10.1056\/NEJMra064928","journal-title":"N Engl J Med"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1513\/AnnalsATS.202212-1019ST","article-title":"Immunocompromised host pneumonia: definitions and diagnostic criteria: an official American Thoracic Society workshop report","volume":"20","author":"Cheng GS","year":"2023","unstructured":"Cheng GS, Crothers K, Aliberti S, et al.. Immunocompromised host pneumonia: definitions and diagnostic criteria: an official American Thoracic Society workshop report. Ann Am Thorac Soc. 2023, 20:341-53. 10.1513\/AnnalsATS.202212-1019ST","journal-title":"Ann Am Thorac Soc"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.1186\/s12941-017-0229-6","article-title":"Diagnostic testing for Legionnaires' disease","volume":"16","author":"Pierre DM","year":"2017","unstructured":"Pierre DM, Baron J, Yu VL, Stout JE. Diagnostic testing for Legionnaires' disease. Ann Clin Microbiol Antimicrob. 2017, 16:59. 10.1186\/s12941-017-0229-6","journal-title":"Ann Clin Microbiol Antimicrob"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.1093\/ajcp\/aqab077","article-title":"Diagnostic value of procalcitonin in transplant patients receiving immunosuppressant drugs: a retrospective electronic medical record-based analysis","volume":"156","author":"Chae H","year":"2021","unstructured":"Chae H, Bevins N, Seymann GB, Fitzgerald RL. Diagnostic value of procalcitonin in transplant patients receiving immunosuppressant drugs: a retrospective electronic medical record-based analysis. Am J Clin Pathol. 2021, 156:1083-91. 10.1093\/ajcp\/aqab077","journal-title":"Am J Clin Pathol"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/j.chest.2020.08.003","article-title":"Management of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies","volume":"158","author":"Hill AT","year":"2020","unstructured":"Hill AT. Management of community-acquired pneumonia in immunocompromised adults: a consensus statement regarding initial strategies. Chest. 2020, 158:1802-3. 10.1016\/j.chest.2020.08.003","journal-title":"Chest"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1378\/chest.95.3_Supplement.187S","article-title":"Role of bronchoalveolar lavage in the diagnosis of pneumonia","volume":"95","author":"Rankin JA","year":"1989","unstructured":"Rankin JA. Role of bronchoalveolar lavage in the diagnosis of pneumonia. Chest. 1989, 95:187-190. 10.1378\/chest.95.3_Supplement.187S","journal-title":"Chest"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.1128\/JCM.01737-13","article-title":"\u03b2-D-glucan testing is important for diagnosis of invasive fungal infections","volume":"51","author":"Theel ES","year":"2013","unstructured":"Theel ES, Doern CD. \u03b2-D-glucan testing is important for diagnosis of invasive fungal infections. J Clin Microbiol. 2013, 51:3478-83. 10.1128\/JCM.01737-13","journal-title":"J Clin Microbiol"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.1016\/j.healun.2010.03.002","article-title":"Invasive biopsy is effective and useful after lung transplant","volume":"29","author":"Burdett CL","year":"2010","unstructured":"Burdett CL, Critchley RJ, Black F, et al.. Invasive biopsy is effective and useful after lung transplant. J Heart Lung Transplant. 2010, 29:759-63. 10.1016\/j.healun.2010.03.002","journal-title":"J Heart Lung Transplant"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.21037\/jtd.2017.01.09","article-title":"The diagnostic yield and complications of open lung biopsies in kidney transplant patients with pulmonary disease","volume":"9","author":"Tomotani DY","year":"2017","unstructured":"Tomotani DY, Bafi AT, Pacheco ES, et al.. The diagnostic yield and complications of open lung biopsies in kidney transplant patients with pulmonary disease. J Thorac Dis. 2017, 9:166-75. 10.21037\/jtd.2017.01.09","journal-title":"J Thorac Dis"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-pathmechdis-012418-012751","article-title":"Clinical metagenomic next-generation sequencing for pathogen detection","volume":"14","author":"Gu W","year":"2019","unstructured":"Gu W, Miller S, Chiu CY. Clinical metagenomic next-generation sequencing for pathogen detection. Annu Rev Pathol. 2019, 14:319-38. 10.1146\/annurev-pathmechdis-012418-012751","journal-title":"Annu Rev Pathol"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1007\/s00117-016-0197-4","article-title":"Pneumonia in immunosuppressed patients (Article in German)","volume":"57","author":"Solyanik O","year":"2017","unstructured":"Solyanik O, Gaass T, Hellbach K, Dinkel J. Pneumonia in immunosuppressed patients (Article in German). Radiologe. 2017, 57:22-8. 10.1007\/s00117-016-0197-4","journal-title":"Radiologe"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.4103\/ijri.IJRI_357_19","article-title":"Imaging spectrum of pulmonary infections in renal transplant patients","volume":"30","author":"Ahmad Z","year":"2020","unstructured":"Ahmad Z, Bagchi S, Naranje P, Agarwal SK, Das CJ. Imaging spectrum of pulmonary infections in renal transplant patients. Indian J Radiol Imaging. 2020, 30:273-9. 10.4103\/ijri.IJRI_357_19","journal-title":"Indian J Radiol Imaging"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.43224","article-title":"The diagnosis and management of herpes simplex pneumonia in the critical care setting: a comprehensive review","volume":"15","author":"Pata R","year":"2023","unstructured":"Pata R, Datar P. The diagnosis and management of herpes simplex pneumonia in the critical care setting: a comprehensive review. Cureus. 2023, 15:e43224. 10.7759\/cureus.43224","journal-title":"Cureus"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/cit929","article-title":"The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia?","volume":"58","author":"Legouge C","year":"2014","unstructured":"Legouge C, Caillot D, Chr\u00e9tien ML, et al.. The reversed halo sign: pathognomonic pattern of pulmonary mucormycosis in leukemic patients with neutropenia?. Clin Infect Dis. 2014, 58:672-8. 10.1093\/cid\/cit929","journal-title":"Clin Infect Dis"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1093\/cid\/ciy760","article-title":"Oral versus aerosolized ribavirin for the treatment of respiratory syncytial virus infections in hematopoietic cell transplant recipients","volume":"68","author":"Foolad F","year":"2019","unstructured":"Foolad F, Aitken SL, Shigle TL, Prayag A, Ghantoji S, Ariza-Heredia E, Chemaly RF. Oral versus aerosolized ribavirin for the treatment of respiratory syncytial virus infections in hematopoietic cell transplant recipients. Clin Infect Dis. 2019, 68:1641-9. 10.1093\/cid\/ciy760","journal-title":"Clin Infect Dis"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.1007\/s00101-020-00879-3","article-title":"Recommendations for treatment of critically ill patients with COVID-19: version 3 S1 guideline","volume":"70","author":"Kluge S","year":"2021","unstructured":"Kluge S, Janssens U, Welte T, et al.. Recommendations for treatment of critically ill patients with COVID-19: version 3 S1 guideline. Anaesthesist. 2021, 70:19-29. 10.1007\/s00101-020-00879-3","journal-title":"Anaesthesist"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1016\/j.jceh.2017.05.011","article-title":"Cytomegalovirus infection in liver transplant recipients: current approach to diagnosis and management","volume":"7","author":"Yadav SK","year":"2017","unstructured":"Yadav SK, Saigal S, Choudhary NS, Saha S, Kumar N, Soin AS. Cytomegalovirus infection in liver transplant recipients: current approach to diagnosis and management. J Clin Exp Hepatol. 2017, 7:144-51. 10.1016\/j.jceh.2017.05.011","journal-title":"J Clin Exp Hepatol"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2013-02-487074","article-title":"CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia","volume":"122","author":"Green ML","year":"2013","unstructured":"Green ML, Leisenring WM, Xie H, et al.. CMV reactivation after allogeneic HCT and relapse risk: evidence for early protection in acute myeloid leukemia. Blood. 2013, 122:1316-24. 10.1182\/blood-2013-02-487074","journal-title":"Blood"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics15010163","article-title":"Optimizing antiviral dosing for HSV and CMV treatment in immunocompromised patients","volume":"15","author":"Huntjens DW","year":"2023","unstructured":"Huntjens DW, Dijkstra JA, Verwiel LN, et al.. Optimizing antiviral dosing for HSV and CMV treatment in immunocompromised patients. Pharmaceutics. 2023, 15:10.3390\/pharmaceutics15010163","journal-title":"Pharmaceutics"},{"key":"ref109","doi-asserted-by":"publisher","DOI":"10.1086\/319225","article-title":"Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients","volume":"32","author":"Singh N","year":"2001","unstructured":"Singh N. Preemptive therapy versus universal prophylaxis with ganciclovir for cytomegalovirus in solid organ transplant recipients. Clin Infect Dis. 2001, 32:742-51. 10.1086\/319225","journal-title":"Clin Infect Dis"},{"key":"ref110","doi-asserted-by":"publisher","DOI":"10.12659\/aot.906164","article-title":"Pharmacokinetic drug-drug interactions between immunosuppressant and anti-infective agents: antimetabolites and corticosteroids","volume":"23","author":"Van Matre ET","year":"2018","unstructured":"Van Matre ET, Satyanarayana G, Page 2nd RL, Levi ME, Lindenfeld J, Mueller SW. Pharmacokinetic drug-drug interactions between immunosuppressant and anti-infective agents: antimetabolites and corticosteroids. Ann Transplant. 2018, 23:66-74. 10.12659\/aot.906164","journal-title":"Ann Transplant"},{"key":"ref111","doi-asserted-by":"publisher","DOI":"10.1128\/aac.00283-22","article-title":"Safety of inhaled amphotericin B lipid complex as antifungal prophylaxis in lung transplant recipients","volume":"66","author":"Huggins JP","year":"2022","unstructured":"Huggins JP, Pease R, Stanly K, Workman A, Reynolds J, Alexander BD. Safety of inhaled amphotericin B lipid complex as antifungal prophylaxis in lung transplant recipients. Antimicrob Agents Chemother. 2022, 66:e0028322. 10.1128\/aac.00283-22","journal-title":"Antimicrob Agents Chemother"},{"key":"ref112","doi-asserted-by":"publisher","DOI":"10.3390\/jof6020084","article-title":"Clinical relevance and characteristics of Aspergillus calidoustus and other Aspergillus species of section Usti","volume":"6","author":"Glampedakis E","year":"2020","unstructured":"Glampedakis E, Erard V, Lamoth F. Clinical relevance and characteristics of Aspergillus calidoustus and other Aspergillus species of section Usti. J Fungi (Basel). 2020, 6:10.3390\/jof6020084","journal-title":"J Fungi (Basel)"},{"key":"ref113","doi-asserted-by":"publisher","DOI":"10.1371\/journal.ppat.1010858","article-title":"Current treatments against mucormycosis and future directions","volume":"18","author":"Smith C","year":"2022","unstructured":"Smith C, Lee SC. Current treatments against mucormycosis and future directions. PLoS Pathog. 2022, 18:e1010858. 10.1371\/journal.ppat.1010858","journal-title":"PLoS Pathog"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/317426-pneumonia-in-transplant-recipients-a-comprehensive-review-of-diagnosis-and-management","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T11:06:41Z","timestamp":1731582401000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/317426-pneumonia-in-transplant-recipients-a-comprehensive-review-of-diagnosis-and-management"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,14]]},"references-count":113,"URL":"https:\/\/doi.org\/10.7759\/cureus.73669","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,14]]}}}